Tranexamic Acid in Hip and Spine Surgery for Children with Cerebral Palsy
Author Information
Author(s): Gould Daniel, Cui Haoze, Ma Norine, Chalkiadis George, Davidson Andrew, Graham Kerr, Rutz Erich
Primary Institution: The Royal Children’s Hospital, University of Melbourne
Hypothesis
What is the impact of TXA on blood loss during hip and spine surgeries for paediatric patients with cerebral palsy?
Conclusion
TXA is generally considered safe but has mixed evidence regarding its efficacy in reducing blood loss during surgeries for children with cerebral palsy.
Supporting Evidence
- TXA was used in 60% of studies with no primary aim related to its administration.
- Most studies focused on spine surgery, with mixed findings on TXA's impact on blood loss.
- TXA dosing regimens varied widely, complicating the interpretation of its efficacy.
Takeaway
This study looked at how a medicine called TXA can help kids with cerebral palsy who need surgery on their hips or backs, but the results were a bit confusing.
Methodology
A scoping review was conducted, screening 14,609 records to include 52 relevant studies on TXA use in surgeries for children with CP.
Potential Biases
Confounding factors included the use of TXA in patients with more severe deformities and higher comorbidity burdens.
Limitations
The literature was heterogeneous, and many studies did not report TXA dosing or outcomes consistently.
Participant Demographics
The studies included children with cerebral palsy undergoing hip or spine surgery, with varying ages and functional levels.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website